These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8860833)

  • 1. TAXI/UAS: A molecular switch to control expression of genes in vivo.
    Delort JP; Capecchi MR
    Hum Gene Ther; 1996 May; 7(7):809-20. PubMed ID: 8860833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory system for use in gene transfer.
    Wang Y; O'Malley BW; Tsai SY; O'Malley BW
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8180-4. PubMed ID: 8058776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-dependent regulation of plasmid-based transgene expression in vivo.
    Abruzzese RV; Godin D; Burcin M; Mehta V; French M; Li Y; O'Malley BW; Nordstrom JL
    Hum Gene Ther; 1999 Jun; 10(9):1499-507. PubMed ID: 10395375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
    Yu YA; Szalay AA
    Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
    Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
    Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells.
    Mader S; White JH
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5603-7. PubMed ID: 8390672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system.
    Luo Y; Batalao A; Zhou H; Zhu L
    Biotechniques; 1997 Feb; 22(2):350-2. PubMed ID: 9043710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter.
    Luna MC; Ferrario A; Wong S; Fisher AM; Gomer CJ
    Cancer Res; 2000 Mar; 60(6):1637-44. PubMed ID: 10749134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloramphenicol acetyltransferase expression as a sensor for fusion activity.
    Gicklhorn D; Eickmann M; Radsak K
    Biotechniques; 1999 Nov; 27(5):902-4, 906, 908. PubMed ID: 10572633
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states.
    Smith CL; Wolford RG; O'Neill TB; Hager GL
    Mol Endocrinol; 2000 Jul; 14(7):956-71. PubMed ID: 10894147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
    Tung L; Mohamed MK; Hoeffler JP; Takimoto GS; Horwitz KB
    Mol Endocrinol; 1993 Oct; 7(10):1256-65. PubMed ID: 8123133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506.
    Butt TR; Graumann K; Aziz S
    Transplant Proc; 1996 Apr; 28(2):979-80. PubMed ID: 8623486
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.
    Beck CA; Weigel NL; Edwards DP
    Mol Endocrinol; 1992 Apr; 6(4):607-20. PubMed ID: 1316549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an improved inducer-regulator protein complex in the pBRES-regulated expression system.
    Levitsky K; Szymanski P; Jin F; Meurer-Ogden JA; Harkins RN
    Hum Gene Ther; 2008 Nov; 19(11):1273-82. PubMed ID: 19000019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3.
    Krikun G; Schatz F; Mackman N; Guller S; Demopoulos R; Lockwood CJ
    Mol Endocrinol; 2000 Mar; 14(3):393-400. PubMed ID: 10707957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
    Yuan W; Yufit T; Li L; Mori Y; Chen SJ; Varga J
    J Cell Physiol; 1999 Apr; 179(1):97-108. PubMed ID: 10082137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.